ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
121.341,13
0,00%
S&P 500
5.464,62
-0,16%
US Dollar vs BRL
5,4304
-0,35%
Bitcoin
61.350,85
-2,86%
Brent Oil
84,645
0,74%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Theratechnologies Inc (THTX)

  7. Theratechnologies Inc (THTX) Notícias

THTX Theratechnologies Inc

1,30
0,00 (0,00%)
Pré-mercado
Última atualização: 08:47:20
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Theratechnologies Inc THTX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,00 0,00% 1,30 08:47:20
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,30
mais cotações »

Notícias Recentes

Data Hora Fonte Título
23/05/202418:00GLOBETheratechnologies’ Sudocetaxel Zendusortide ASCO 2024..
09/05/202417:30GLOBETheratechnologies Reports on its Annual Meeting of..
02/05/202408:30GLOBETheratechnologies to Present Long-Term Efficacy, Safety and..
15/04/202417:15GLOBETheratechnologies Announces Mailing of Management Proxy..
11/04/202408:30GLOBETheratechnologies to Present at the 2024 Bloom Burton & Co...
10/04/202408:30GLOBETheratechnologies Reports Financial Results and Provides..
10/04/202408:15IHMARKETNEWSU.S. Index Futures Show Mixed Trend Ahead of Key Inflation..
08/04/202417:30GLOBETheratechnologies Preclinical Data Presentation at AACR 2024..
05/04/202412:00GLOBETheratechnologies Appoints Elina Tea to its Board of..
03/04/202408:30GLOBETheratechnologies to Announce First Quarter 2024 Financial..
28/03/202408:30GLOBETheratechnologies to Present Preclinical Data at AACR on..
22/03/202410:36GLOBETheratechnologies Announces Update on its Preclinical..
21/03/202421:00GLOBETheratechnologies Appoints Jordan Zwick to its Board of..
21/03/202408:30GLOBETheratechnologies Initiates Increased Dose Level in Phase 1..
29/02/202418:34GLOBETheratechnologies Announces the Resignation of One of Its..
27/02/202409:30GLOBETheratechnologies Receives Refusal to File Letter for..
21/02/202409:30GLOBETheratechnologies Reports Financial Results for the Fourth..
20/02/202409:30GLOBETheratechnologies Announces Publication in Frontiers in..
15/02/202409:30GLOBETheratechnologies Completes Enrollment of First Six Patients..
06/02/202409:30GLOBETheratechnologies to Announce Fourth Quarter and Full Year..
24/01/202409:00GLOBETheratechnologies Receives Complete Response Letter (CRL)..
23/01/202409:30GLOBETheratechnologies Receives Update from FDA on Tesamorelin F8..
02/01/202411:00APSWill This Dual-Listed Bio-Pharma Catch New Year Action?
02/01/202409:30GLOBETheratechnologies Submits sBLA for Trogarzo® Intramuscular..
21/12/202318:12PRNCATheratechnologies annonce le renouvellement de son..
21/12/202318:09PRNUSTheratechnologies Announces Renewal of Shelf Prospectus and..
13/12/202309:30GLOBETheratechnologies Announces FDA Approval of Trogarzo®..
24/11/202309:30GLOBETheratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation..
31/10/202313:34GLOBETheratechnologies Announces Closing of US$25 Million Public..
26/10/202309:00GLOBETheratechnologies Announces Pricing of US$25 Million Public..
25/10/202317:13GLOBETheratechnologies Announces Proposed Public Offering of..
24/10/202308:00GLOBETheratechnologies Announces Operational Update
19/10/202308:30GLOBETheratechnologies’ Ibalizumab Demonstrates..
16/10/202308:30GLOBETheratechnologies Announces Finalization of Amendments to..
13/10/202308:30GLOBETheratechnologies Presents Data at ID Week Showing..
13/10/202308:00GLOBETheratechnologies Announces Results from Trogarzo®..
12/10/202308:30GLOBETheratechnologies Announces Dosing of First Patient in..
04/10/202308:30GLOBETheratechnologies Receives January 2024 PDUFA Goal Date for..
26/09/202308:34IHMARKETNEWSTuesday’s Wall Street Highlights: Ford Motor, Coty,..
26/09/202308:30GLOBETheratechnologies Reports Financial Results for the Third..
25/09/202308:30GLOBETheratechnologies Announces Agreement in Principle with..
25/09/202308:00GLOBETheratechnologies Submits Tesamorelin F8 Formulation sBLA..
20/09/202308:00GLOBETheratechnologies to Present at the Cantor Fitzgerald Global..
18/09/202317:15GLOBETheratechnologies to Announce Third Quarter 2023 Financial..
07/09/202314:57GLOBETheratechnologies to Present at the H.C. Wainwright 25th..
05/09/202308:00GLOBETheratechnologies Announces Certain Preliminary Q3 2023..
30/08/202311:34GLOBETheratechnologies Announces All U.S. Oncology Clinical Sites..
31/07/202310:00APSBiopharma Firm Completes Reverse Stock Split
31/07/202308:00GLOBETheratechnologies Completes 1-for-4 Reverse Stock Split
28/07/202317:44GLOBETheratechnologies Announces Amendments to its Term Loan..

Seu Histórico Recente

NASDAQ
THTX
Theratechnologies
NYSE
KED
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados